Search results
Results from the WOW.Com Content Network
Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company that's been publicly traded for decades. The healthcare testing specialist's share price ...
Quest Diagnostics (DGX) closed the most recent trading day at $118.40, moving -0.08% from the previous trading session. This move was narrower than the S&P 500's daily loss of 0.22%.
Let's see if Quest Diagnostics (DGX) stock is a good choice for value-oriented investors right now from multiple angles.
For premium support please call: 800-290-4726 more ways to reach us
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States , Puerto Rico , Mexico , and Brazil . [ 3 ] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Stock name Symbol Country of origin Q2 Holdings, Inc. QTWO: US Qiagen N.V. QGEN: Netherlands: Quad/Graphics, Inc. QUAD: US Quaker Chemical Corporation: KWR: US Quanex Building Products Corporation NX: US Quanta Services Inc. PWR: US Quantum FinTech Acquisition Corporation QFTA: US Quantum FinTech Acquisition Corporation QFTA.UN: US QuantumScape ...
Let's see if Quest Diagnostics Incorporated (DGX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Celera Corporation is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera , spun off into an independent company in 2008, and finally acquired by Quest Diagnostics in 2011.